This review summarizes current applications and clinical utility of diffusion-weighted imaging
(DWI) for rectal cancer and in addition provides a brief overview of more recent …

After neoadjuvant radiochemotherapy (RCT) for locally advanced rectal cancer, 15–27% of
the patients experience a pathological complete response (pCR). This observation raises …

Aim Pathological complete response to neoadjuvant chemoradiotherapy is found in 20% of
patients with rectal cancer undergoing long‐course chemoradiotherapy. Some authors have …

Rectal adenocarcinoma is an important cause of cancer-related deaths worldwide, and key
anatomic differences between the rectum and the colon have significant implications for …

Despite advances in multimodality treatment strategies for locally advanced rectal cancer
and improvements in locoregional control, there is still a considerable variation in response …

BACKGROUND: Conventional MRI is limited in the assessment of nodal status and T status
after neoadjuvant chemoradiotherapy. Multiparametric MRI strives to overcome these issues …

Background: To compare the diagnostic performance of radiomics models with that of
dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) perfusion parameters …

Objectives This study was conducted in order to determine the prognostic value of MRI for
extramural venous invasion (EMVI) in rectal cancer compared to pathology and to assess …

PURPOSE: To evaluate the diagnostic performance of quantitative apparent diffusion
coefficient (ADC) measurements, in the assessment of the therapeutic response to chemo …

Purpose To investigate the usefulness of apparent diffusion coefficient (ADC) values derived
from histogram analysis of the whole rectal cancer as a quantitative parameter to evaluate …